Intracranial Arteriosclerosis: Clinical Trials

23 trials for Intracranial Arteriosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 3 not yet recruiting, 3 recruiting. 23 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 423Completed 7, Unknown 4, Not yet recruiting 3, Recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1, Terminated 1

Follow Intracranial Arteriosclerosis: new trials by email Literature Review of Intracranial Arteriosclerosis trials Research Report on Intracranial Arteriosclerosis

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Intervention 1, Intervention 3, Intervention 2 - Atherosclerosis Cerebral, Carotid Plaque
Phase 4Not yet recruitingKeqiang Zhao1202027-01-012026-09-15
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial
Rosuvastatin, Ezetimibe, Recaticimab - Intracranial Arteriosclerosis, Cognitive Impairment
Phase 4Not yet recruitingPeking Union Medical College Hospital4402026-09-172026-09-15
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
Recaticimab plus standard therapy, Recaticimab's placebo in combination with standard therapy - Acute Ischemic Stroke AIS, Intracranial Atherosclerosis ICAS
Phase 4Not yet recruitingPeking Union Medical College Hospital12122026-09-012026-07-15
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Apixaban, Clopidogrel - Stroke, Ischemic
Phase 4RecruitingYonsei University5862026-07-142026-11-18
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Mexidol sequential therapy - Metabolic Abnormalities, Obesity & Overweight
Phase 4Active not recruitingResearch Center of Neurology, Russia302026-04-012026-11-06
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Recaticimab and Statin, Statin - Intracranial Atherosclerosis, Intracranial Artery Stenosis
Phase 4RecruitingPeking Union Medical College Hospital3002025-11-072026-06-12
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
clopidogrel for 90 days combined with aspirin for 90 days, clopidogrel for 30 days combined with aspirin for 90 days - Ischemic Stroke, Intracranial Arteriosclerosis
Phase 4UnknownSichuan Provincial People's Hospital11002024-07-012024-06-18
High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
Evolocumab 140 MG/ML, Intensive statin treatment - Cerebral Atherosclerosis
Phase 4UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology2002022-11-092023-12-11
Reducing Intracranial atheroSclErosis With Repatha
Repatha - Ischemic Stroke
Phase 4TerminatedUniversity of California, Los Angeles102021-04-232023-03-15
Predicting Stroke Risk in ICAD With Novel MRI
Feraheme - Intracranial Atherosclerosis
Phase 4WithdrawnNorthwestern University2020-09-012026-08-06
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
Atorvastatin 40 Mg Oral Tablet, Placebo - Dementia, Mixed, Dementia, Vascular
Phase 4Active not recruitingMonash University3412019-09-192025-05-22
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
Atorvastatin Calcium, Probucol, PCSK9 inhibitor - Stroke, Ischemic, Atherosclerosis, Cerebral
Phase 4RecruitingGeneral Hospital of Shenyang Military Region1002018-12-012026-04-27
Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis
Divaza, Placebo - Cerebral Atherosclerosis
Phase 4CompletedMateria Medica Holding1242018-04-122021-08-26
Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis
Urinary Kallikrein - Intracranial Arteriosclerosis, Collateral Circulation
Phase 4WithdrawnSecond Affiliated Hospital, Zhejiang University, School of Medicine2016-01-012020-03-30
Efficacy of Pain Treatment on Depression in Patients With Dementia
Paracetamol, Buprenorphine, Paracetamol placebo - Depression, Pain
Phase 4CompletedUniversity of Bergen1632014-08-012017-04-04
Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis
High-dose statin: Atorvastatin 40mg or Rosuvastatin 20mg - Stroke, Intracranial Atherosclerosis
Phase 4UnknownSamsung Medical Center802012-02-012017-04-26
Imaging of Brain Amyloid Plaques in the Aging Population
Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies
Phase 4Enrolling by invitationMayo Clinic80002008-04-012026-06-23
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
Cilostazol, Aspirin - Vascular Dementia, Stroke
Phase 4CompletedPeking University First Hospital2002008-03-012015-05-06
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN - Alzheimer Disease, Dementia
Phase 4CompletedVA Office of Research and Development112007-10-012015-11-20
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Cerebrolysin, 0.9% Saline Solution - Vascular Dementia
Phase 4CompletedEver Neuro Pharma GmbH2422006-10-012024-02-21

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Dementia, Vascular (7)  ·  Stroke (5)  ·  Ischemic Stroke (4)  ·  Alzheimer Disease (3)  ·  Dementia (3)  ·  Atherosclerosis (2)  ·  Atrial Fibrillation (2)  ·  Cerebrovascular Disorders (2)  ·  Cognitive Dysfunction (2)  ·  Coronary Disease (2)  ·  Lewy Body Disease (2)  ·  Pain (2)  ·  Plaque, Atherosclerotic (2)  ·  Agnosia (1)

Broader conditions

Arterial Occlusive Diseases (23)  ·  Brain Diseases (23)  ·  Central Nervous System Diseases (23)  ·  Intracranial Arterial Diseases (23)  ·  Nervous System Diseases (23)  ·  Vascular Diseases (23)  ·  Arteriosclerosis (22)  ·  Cardiovascular Diseases (22)  ·  Cerebrovascular Disorders (21)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Mental Disorders (8)  ·  Neurocognitive Disorders (8)  ·  Leukoencephalopathies (7)  ·  Stroke (5)

Interventions

Atorvastatin (4)  ·  Aspirin (3)  ·  evolocumab (3)  ·  Clopidogrel (2)  ·  Rosuvastatin Calcium (2)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  Acetaminophen (1)  ·  Adrenergic beta-Antagonists (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Atenolol (1)  ·  Buprenorphine (1)  ·  Cilostazol (1)  ·  Donepezil (1)  ·  Ezetimibe (1)  ·  Ferrosoferric Oxide (1)

Sponsors

Peking Union Medical College Hospital (3)  ·  Eisai Inc. (1)  ·  Ever Neuro Pharma GmbH (1)  ·  Far Eastern Memorial Hospital (1)  ·  General Hospital of Shenyang Military Region (1)  ·  Johns Hopkins University (1)  ·  Keqiang Zhao (1)  ·  Materia Medica Holding (1)  ·  Mayo Clinic (1)  ·  Monash University (1)  ·  Northwestern University (1)  ·  Peking University First Hospital (1)  ·  Research Center of Neurology, Russia (1)  ·  Samsung Medical Center (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (8)  ·  United States (5)  ·  Russia (3)  ·  South Korea (2)  ·  Australia (1)  ·  Norway (1)  ·  Philippines (1)  ·  Taiwan (1)

Top investigators

A H Li, MD (1)  ·  Andrea Snow, PhD MS BS (1)  ·  Ane Erdal, PhD candidate (1)  ·  Bo Hu, Doctor (1)  ·  Candong Hong, Doctor (1)  ·  Elisabeth Flo, PhD (1)  ·  Huang Yining, MD PhD (1)  ·  Huisheng Chen, Doctor (1)  ·  Jacqueline Dominguez (1)  ·  Jerilyn Allen (1)  ·  Jie Yang, doctor (1)  ·  Jiehong Wu, Doctor (1)  ·  Lei Zhang, Doctor (1)  ·  Min Lou, Ph.D,M.D. (1)

Results publications

PMID 28304224, PMID 17548554, PMID 17548555, PMID 20656516, PMID 21899409, PMID 21953407, PMID 24489130, PMID 27846344, PMID 29487556, PMID 29725986, PMID 30066942, PMID 31011477, PMID 31371644, PMID 31707788, PMID 31886149, PMID 32561535, PMID 32817184, PMID 33189083, PMID 34353533, PMID 35048716, PMID 35143758, PMID 35833913, PMID 35943472, PMID 37009731, PMID 37056360, PMID 37738517, PMID 37920607, PMID 38048667, PMID 38212060, PMID 38648030, PMID 38817546, PMID 39087353, PMID 39387764, PMID 39505412, PMID 39548030, PMID 39755915, PMID 39818872, PMID 40616232, PMID 40820974, PMID 41107765, PMID 41389830, PMID 41500725, PMID 41582814, PMID 42262770

NIH funding

R01AG011378 (1), R01HL082638 (1), U01AG006786 (1)